Ir para o conteúdo principal

Grafa News and Videos — Page 1049

Destaques de Grafa

Grafa

FDA grants priority review to Pfizer and Astellas for Padcev-Keytruda combo in MIBC

Pfizer (NYSE:PFE) and Astellas announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for the perioperative use of Padcev (enfortumab vedotin-ejfv) in combination with Keytruda (pembrolizumab).

Leia mais: FDA grants priority review to Pfizer and Astellas for Padcev-Keytruda combo in MIBC

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas